Video presentation of real-world research on the impact of upfront chemo choice on second-line immunotherapy in bladder cancer. CONTEXT: Lead author Benjamin Miron presents findings of a real-world study into Continue Reading
Liquid biopsies can match non-small cell lung cancer (NSCLC) patients to life-prolonging targeted therapy CONTEXT: Liquid biopsies can match non-small cell lung cancer (NSCLC) patients to life-prolonging targeted therapy and Continue Reading
Holmusk and Otsuka team up to develop real-world evidence based behavioural health platform. CONTEXT: Commercial announcement that Holmusk and Otsuka are partnering to develop one of the largest real-world evidence Continue Reading
Real-World research study reveals less than half of NSCLC patients receive comprehensive biomarker testing prior to receiving 1st line therapy. CONTEXT: A retrospective chart review of metastatic NSCLC patients presented Continue Reading
Retrospective real-world research study on multiple myeloma therapy in China CONTEXT: This abstract with reference to full article originally published in Leuk Lymphoma Journal is a retrospective analysis of newly Continue Reading
Lenvatinib superior to sorafenib in patients with unresectable hepatocellular carcinoma CONTEXT: Results from a poster presentation at the World Congress on Gastrointestinal Cancer showed lenvatinib was superior to sorafenib as Continue Reading
Hungarian real-world research study confirms tolerability of palbociclib similar to registration trials in breast cancer patients. CONTEXT: A retrospective review of 962 Hungarian breast cancer patients published in OncoTargets and Continue Reading
CONTEXT: Announcement of AMCP Foundation award for Best Poster going to real-world studies in cancer and neurological disease, underscoring the importance of capturing and integrating real-world evidence. IMPACT: Low READ Continue Reading
CONTEXT: A significant announcement from ConcertAI as they start a 5-year collaborative research programme with the FDA’s Center for Drug Evaluation and Research (CDER). The aim of the research is Continue Reading
CONTEXT: Presentation at the European Hematology Association (EHA) 2021 Virtual Congress of a post-approval safety study on Truxima (biosimiliar rituximab) in patients with large B-cell lymphoma. Results showed similar results Continue Reading
